Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$147,430,590
+$39,132,099 QoQ
Shares Held
585,879
+17.7% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#194
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$503,280
CallShares
2,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tidal Investments LLC holds $1,286,079,316 across 16 Drug Manufacturers - General names. ABBV ranks #3 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
399,953 | $479,715,664 | |
| 2 | JNJ |
Johnson & Johnson
|
793,471 | $201,517,828 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
585,879 | $147,430,590 | |
| 4 | MRK |
Merck & Co., Inc.
|
932,100 | $119,774,849 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
545,861 | $68,964,077 | |
| 6 | AMGN |
Amgen Inc
|
178,875 | $64,774,213 | |
| 7 | PFE |
Pfizer Inc
|
1,971,885 | $47,482,989 | |
| 8 | AZN |
Astrazeneca PLC
|
248,108 | $47,046,238 |
All Filings in ABBV
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $503,280 | 2,000 | Call | Sole | 2026-08-13 | |
| 2026-06-30 | $147,430,590 | 585,879 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $108,298,491 | 497,947 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $45,721,305 | 200,102 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $251,339 | 1,100 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $37,883,880 | 163,617 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $25,873,385 | 139,389 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $27,211,410 | 129,875 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $24,121,353 | 135,742 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $10 | 2 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $22,389,295 | 113,375 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $19,312,293 | 112,595 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $18,215,279 | 100,029 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $10,411,504 | 67,184 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $11,499,680 | 77,148 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $9,895,918 | 73,450 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,753,199 | 92,572 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $12,299,651 | 76,107 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $9,912,884 | 73,861 | Shares | Sole | 2022-11-23 | |
| 2022-06-30 | $10,594,077 | 69,170 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,155,437 | 68,814 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $7,571,161 | 55,917 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $5,204,296 | 48,246 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,244,933 | 28,808 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,847,856 | 17,075 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,234,046 | 11,517 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $646,939 | 7,386 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $626,388 | 6,380 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $321,674 | 4,222 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||